Curative Biotechnology Stock

Curative Biotechnology Liabilities

The The Liabilities of Curative Biotechnology (CUBT) as of Aug 16, 2026 is 730,300.00 USD. In the previous year, The Liabilities was 665,000.00 USD — a change of 9.82% (higher).

Liabilities

730,300.00USD

YoY

9.82%

Last updated:

In 2026, Curative Biotechnology's total liabilities amounted to 730,300.00 USD, a 9.82% difference from the 665,000.00 USD total liabilities in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Curative Biotechnology Stock analysis

What does Curative Biotechnology do? Curative Biotechnology is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Curative Biotechnology's Liabilities

Curative Biotechnology's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Curative Biotechnology's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Curative Biotechnology's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Curative Biotechnology's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Curative Biotechnology’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Curative Biotechnology stock

The Liabilities of Curative Biotechnology is 730,300.00 USD in 2026.

The Liabilities of Curative Biotechnology changed from 665,000.00 USD to 730,300.00 USD, representing a 9.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Curative Biotechnology since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Curative Biotechnology historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Curative Biotechnology

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Curative Biotechnology